Stop Cefuroxime Immediately
Given the patient's history of prior antibiotic-associated diarrhea (possible C. difficile) and current loose stools on day 3 of cefuroxime, you should discontinue the cefuroxime now rather than completing the planned course. The risk of developing or worsening C. difficile infection (CDI) far outweighs any benefit from continuing this third-generation cephalosporin.
Why Stop Now
Cefuroxime is High-Risk for CDI
Cephalosporins, particularly third-generation agents like cefuroxime, are among the antibiotics most strongly associated with CDI 1, 2. The FDA label explicitly warns that Clostridioides difficile-associated diarrhea (CDAD) has been reported with cefuroxime use and may range from mild diarrhea to fatal colitis 3.
Prior CDI History is a Major Red Flag
This patient has a documented history of antibiotic-associated diarrhea with possible CDI. Previous episodes of CDI carry an odds ratio of 3.87 for recurrent CDI 2. Once someone has had CDI, their risk of recurrence with subsequent antibiotic exposure is dramatically elevated.
Current Symptoms Suggest Active Problem
The loose stools on day 3 are concerning for:
- Early CDI recurrence (most likely given history)
- Antibiotic-associated diarrhea without CDI
- Either way, continuing cefuroxime worsens both conditions
What to Do Right Now
1. Stop the Cefuroxime Immediately
Discontinuation of unnecessary antibiotics is strongly recommended for the management of CDI 2. A meta-analysis showed that continued use of antibiotics for infections other than CDI is significantly associated with increased risk of CDI recurrence 1.
2. Assess if the Original Infection Still Requires Treatment
- If the original infection (reason for cefuroxime) has clinically improved after 3 days, stopping is appropriate
- If continued antibiotic therapy is absolutely necessary, switch to an agent less associated with CDI: parenteral aminoglycosides, sulfonamides, macrolides, or tetracycline/tigecycline 1
3. Test for C. difficile NOW
Send stool for:
- Two-step testing: Glutamate dehydrogenase (GDH) plus toxin enzyme immunoassay 4
- OR nucleic acid amplification test (NAAT) alone in appropriate clinical context 4
- Do NOT test formed stool - only test if diarrhea continues (≥3 unformed stools in 24 hours) 2, 4
4. Do NOT Empirically Treat CDI Yet
Wait for test results unless:
- Diarrhea worsens significantly
- Fever develops
- Abdominal pain becomes severe
- Patient becomes hemodynamically unstable
Critical Pitfalls to Avoid
Do not "finish the course" just because it was prescribed for 5 days. The outdated notion of completing antibiotic courses regardless of clinical response has been replaced by evidence-based stewardship. In this high-risk patient with concerning symptoms, continuing cefuroxime for 2 more days could trigger fulminant CDI.
Do not assume this is just "normal antibiotic diarrhea." With her history, any loose stools on antibiotics should be considered CDI until proven otherwise.
Do not use anti-motility agents (loperamide). If this is CDI, antimotility drugs can precipitate toxic megacolon 5.
If CDI is Confirmed
Should testing confirm CDI:
- First-line treatment: Vancomycin 125 mg PO four times daily for 10 days 2, 6
- Alternative: Fidaxomicin 200 mg PO twice daily for 10 days (preferred for recurrent CDI due to lower recurrence rates) 6
- Do NOT use metronidazole in someone with prior CDI history - it's inferior to vancomycin and only recommended for first episodes in low-risk patients 2, 7
The Bottom Line
Three days of cefuroxime is enough - stop it now. The combination of prior CDI history, high-risk antibiotic choice, and current loose stools creates unacceptable risk for serious complications including recurrent CDI, pseudomembranous colitis, or toxic megacolon. The FDA label specifically states that if CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may need to be discontinued 3.